Search

The correlation between high socioeconomic status (SES) and better survival outcome in patients with either Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL) was well-established in the pre-rituximab era. However, whether or not such an association exists in the post-retuxamib era has not been reliably demonstrated. Herein we conducted a population-based study in Taiwan involving 5010 patients diagnosed between 2002 and 2006 to investigate the relationship between individual and neighborhood SES and survival outcomes for lymphoma. A proxy measure of individual SES is based on income-related insurance payment, and neighborhood SES is based on neighborhood household income.